# Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

> **NCT07727642** · NA · RECRUITING · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 60 (estimated)

## Conditions studied

- AIDS-related Lymphoma
- HIV Infection

## Interventions

- **DRUG:** Oral Antiretroviral Therapy
- **DRUG:** albuvirtide
- **DRUG:** Cabotegravir/Rilpivirine

## Key facts

- **NCT ID:** NCT07727642
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-26
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727642, "Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*